Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Vasarmidi (Heraklion (Crete), Greece), E. Tsitoura (Heraklion (Crete), Greece), S. Mastrodemou (Heraklion (Crete), Greece), A. Trachalaki (Heraklion (Crete), Greece), N. Tzanakis (Heraklion (Crete), Greece), K. Antoniou (Heraklion (Crete), Greece). Levels of oxidised mitochondria in BAL macrophages in fibrotic ILDs.. 603

Member's Comments

No comment yet.

Related content which might interest you: Let7c and AKT1/AKT2 mRNA balance is different In IPF BAL cells compared to other fibrotic ILDs. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Iron and lipid content in serum and alveolar macrophages obtained by bronchoalveolar lavage in experimental pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001 Analysis of antioxidant proteins and oxidized proteins in BAL of patients with interstitial lung diseases Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004 BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Increased BALF eosinophils and underlying interstitial lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Elevated percentage of hemosiderin-laden macrophages in the BAL fluid of patients with diffuse alveolar damage Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage Source: Eur Respir J 2009; 33: 1361-1366 Year: 2009 BALF phospholipids and cytokines released by alveolar macrophages in the differential diagnosis of pulmonary sarcoidosis and tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002 CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer. Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Detection of extracellular proteasome in the human alveolar space Source: Annual Congress 2006 - Molecular airway biology Year: 2006 Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation? Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis Source: International Congress 2015 – IPF pathogenesis Year: 2015 Lysosomal iron in pulmonary alveolar proteinosis: a case report Source: Eur Respir J 2009; 33: 673-679 Year: 2009 Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL Source: Eur Respir J 2003; 22: 497-502 Year: 2003 Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Extracellular vesicles from broncho-alveolar lavage act on cellular behavior during lung fibrosis. Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018 Increased haemosiderin-laden alveolar macrophages in IPF patients Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Lipid-laden macrophage index and inflammation in bronchoalveolar lavage fluids in children Source: Eur Respir J 2001; 18: 790-795 Year: 2001 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015